To promote the development of accessible infectious disease diagnostics through multidisciplinary innovation along the development pipeline from research to impact in different global settings.
Half of the world’s population has little to no access to diagnostics for infectious diseases, even though they often carry the global burden. Almost every global health priority (antimicrobial resistance, global health security) depends on better access to quick and accurate diagnostic tests for infectious diseases.
Our center identifies promising emerging technologies, particularly those that are affordable and useful in low- resource settings and facilitates their translational movement along the development pipeline into clinical assessment and commercialization.
